Vanda Pharmaceuticals (VNDA) Non-cash Items (2009 - 2018)
Vanda Pharmaceuticals recorded quarterly Non-cash Items of $28.6 million in Q1 2018, up 17.06% quarter-over-quarter from $24.4 million in Q4 2017, and up 157.54% year-over-year from $11.1 million in Q1 2017.
Vanda Pharmaceuticals' Non-cash Items history runs 10 years deep, the most recent figure standing at $28.6 million for Q1 2018.
- In Q1 2018, Non-cash Items rose 157.54% year-over-year to $28.6 million; the TTM figure through Mar 2018 stood at $28.6 million (up 157.54% YoY), while the FY2017 annual figure was $24.4 million, down 24.75% from the prior year.
- Non-cash Items came in at $28.6 million for Q1 2018 at Vanda Pharmaceuticals, up from $24.4 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $34.8 million in Q1 2014 to a low of $594082.0 in Q1 2015.
- A 5-year average of $12.0 million and a median of $4.4 million in 2016 frame the typical range for Non-cash Items.
- Across the five-year window, Non-cash Items jumped 4494.59% in 2014 and slumped 98.29% in 2015, its largest moves.
- Vanda Pharmaceuticals' Non-cash Items stood at $28.5 million in 2014, then tumbled by 73.71% to $7.5 million in 2015, then surged by 332.82% to $32.5 million in 2016, then retreated by 24.75% to $24.4 million in 2017, then advanced by 17.06% to $28.6 million in 2018.
- According to Business Quant data, Non-cash Items over the past three periods registered $28.6 million, $24.4 million, and $3.4 million for Q1 2018, Q4 2017, and Q3 2017 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 28.59 Mn |
| Mar 31, 2018 | 28.59 Mn |
| Dec 31, 2017 | 24.42 Mn |
| Dec 31, 2017 | 24.42 Mn |
| Sep 30, 2017 | 3.38 Mn |
| Sep 30, 2017 | 3.38 Mn |
| Jun 30, 2017 | 10.00 Mn |
| Jun 30, 2017 | 10.00 Mn |
| Mar 31, 2017 | 11.10 Mn |
| Mar 31, 2017 | 11.10 Mn |
| Dec 31, 2016 | 32.45 Mn |
| Dec 31, 2016 | 32.45 Mn |
| Sep 30, 2016 | 3.91 Mn |
| Sep 30, 2016 | 3.91 Mn |
| Jun 30, 2016 | 4.36 Mn |
| Jun 30, 2016 | 4.36 Mn |
| Mar 31, 2016 | 4.44 Mn |
| Mar 31, 2016 | 4.44 Mn |
| Dec 31, 2015 | 7.50 Mn |
| Dec 31, 2015 | 7.50 Mn |
| Sep 30, 2015 | 3.96 Mn |
| Sep 30, 2015 | 3.96 Mn |
| Jun 30, 2015 | 4.15 Mn |
| Jun 30, 2015 | 4.15 Mn |
| Mar 31, 2015 | 594,082.00 |
| Mar 31, 2015 | 594,082.00 |
| Dec 31, 2014 | 28.52 Mn |
| Dec 31, 2014 | 28.52 Mn |
| Sep 30, 2014 | 652,810.00 |
| Sep 30, 2014 | 652,810.00 |
| Jun 30, 2014 | 652,810.00 |
| Jun 30, 2014 | 652,810.00 |
| Mar 31, 2014 | 34.83 Mn |
| Mar 31, 2014 | 34.83 Mn |
| Dec 31, 2013 | 8.21 Mn |
| Dec 31, 2013 | 8.21 Mn |
| Sep 30, 2013 | 3.34 Mn |
| Sep 30, 2013 | 3.34 Mn |
| Jun 30, 2013 | 300,000.00 |
| Jun 30, 2013 | 300,000.00 |
| Mar 31, 2013 | 758,000.00 |
| Mar 31, 2013 | 758,000.00 |
| Dec 31, 2012 | 1.51 Mn |
| Dec 31, 2012 | 1.51 Mn |
| Dec 31, 2011 | 2.02 Mn |
| Dec 31, 2011 | 2.02 Mn |
| Dec 31, 2010 | 3.43 Mn |
| Dec 31, 2010 | 3.43 Mn |
| Dec 31, 2009 | 6.80 Mn |
| Dec 31, 2009 | 6.80 Mn |